A bold title for a post that I will not be without controversy.
Pandora Much has been spoken of empowerment, shared responsibility between patient and clinician and explored ways of implementing these conceptos.
Pero la corresponsabilidad no afecta sólo a estos dos actores... no afecta sólo a los centros y a la Administración Sanitaria: afecta también a la industria.
Afecta también a las Big Pharma...
¡Vaya!, pensarán algunos...
La realidad es que las Big Pharma se encuentran delante de su ser o no ser en un espacio temporal de unos 15 años... se va a transformar su modelo de negocio y su modo de efectuar placement de productos como hasta ahora no se había visto.
Sí, es cierto, su modo primario de placement, dissemination, it will not change immediately, the binomial visitor and sponsorship is going to stay ... but you will lose weight.
Remember we talked about patient-responsible, informed, discerning, able to deal equally with its clinical reference.
patient informed patient is not only able to find and assimilate information, but can find and other methods of treatment.
An informed patient, a patient who has the ability to influence ... prescriber is a liability.
The Big Pharma had already faced challenges similar: psychologists, physiotherapists and prescribers Nurse @ s are passive ... that are within health centers.
What will happen to the e-patients?
Do visitors go door to door?
No, I do not.
The answer lies in social media.
0 comments:
Post a Comment